Russell Investments Group’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,852
Closed -$19K 3107
2019
Q2
$19K Sell
1,852
-214
-10% -$2.43K ﹤0.01% 2798
2019
Q1
$29K Buy
2,066
+175
+9% +$3.01K ﹤0.01% 2855
2018
Q4
$30K Hold
1,891
﹤0.01% 2840
2018
Q3
$36K Hold
1,891
﹤0.01% 2864
2018
Q2
$36K Sell
1,891
-40
-2% -$811 ﹤0.01% 2846
2018
Q1
$40K Hold
1,931
﹤0.01% 2845
2017
Q4
$39K Sell
1,931
-9,470
-83% -$176K ﹤0.01% 2892
2017
Q3
$210K Sell
11,401
-1,149
-9% -$25.3K ﹤0.01% 2655
2017
Q2
$313K Sell
12,550
-1,600
-11% -$33.6K ﹤0.01% 2578
2017
Q1
$284K Buy
14,150
+1,782
+14% +$39.1K ﹤0.01% 2620
2016
Q4
$297K Buy
+12,368
New +$277K ﹤0.01% 2625

Other funds holding PMD

Russell Investments Group's PMD Position: Q3 2019 in Review

Russell Investments Group sold out of Psychemedics Corporation (PMD) in Q3 2019, closing a stake of 1,852 shares — an estimated $19K sold.

Russell Investments Group first reported a position in PMD in Q4 2016 and held it in 11 quarters. The position peaked at $313K in Q2 2017. 45 funds tracked by Wall St. Rank hold PMD as of Q3 2019.

  • Russell Investments Group reported no remaining Psychemedics Corporation position as of Q3 2019 after selling out during the quarter.
  • Russell Investments Group sold 1,852 Psychemedics Corporation shares in Q3 2019, an estimated $19K.
  • Russell Investments Group first reported a position in Psychemedics Corporation in Q4 2016 and held it in 11 quarters.
  • Russell Investments Group's Psychemedics Corporation position peaked at $313K in Q2 2017.
  • 45 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q3 2019.

Based on Russell Investments Group's 13F filing for Q3 2019, filed 1 Nov 2019.